| Dawn Kokernak, MSW | |
|
120 Bedford Center Rd, Ste. 302, Bedford, NH 03110-5442 | |
| (603) 472-5117 | |
| Not Available |
| Full Name | Dawn Kokernak |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 120 Bedford Center Rd, Bedford, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598860652 | NPI | - | NPPES |
| 1400567Y0NH01 | Other | NH | ANTHEM BLUE CROSS BLUE SH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 272 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dawn Kokernak, MSW 43 Bourne Dr, Bedford, NH 03110-6849 Ph: (603) 472-5117 | Dawn Kokernak, MSW 120 Bedford Center Rd, Ste. 302, Bedford, NH 03110-5442 Ph: (603) 472-5117 |
News Archive
A Korea-based company EyeGene Inc. has recently developed a liposome-based mRNA candidate vaccine against COVID-19, which contains full-length spike protein of the European variant (D614G) of SARS-CoV-2 as a vaccine antigen.
Antares Pharma, Inc. and the Population Council today announced successful results from a dose-finding Phase 2 trial for a novel contraceptive gel containing the progestin Nestorone and estradiol (NES/E2) utilizing the Antares ATD (advanced transdermal delivery) gel system. Based on this successful data, the two parties continue to expect to partner with a worldwide or regional pharmaceutical company in order to commercialize this novel contraceptive gel.
Entellus Medical, a Minnesota-based medical technology company, today announced the launch of its PathAssist™ Light Seeker™ at the annual meeting of the American Academy of Otolaryngology-Head and Neck Surgery in San Francisco.
This National Diabetes Month, there is some good news for people with eye complications from diabetes. Earlier this month, a network of researchers supported by the National Eye Institute (NEI) found that the drug Lucentis (ranibizumab) can be highly effective for treating proliferative diabetic retinopathy, an eye disease that can occur as a complication of diabetes.
Eliminating tens of thousands of manual lab experiments, two University of Houston (UH) professors are working toward a method to cut the development time of new antibiotics. While current practices typically last for more than a decade, a computerized modeling system being developed at UH will speed up this process.
› Verified 3 days ago
Dina Landis Solomon, Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 82 Palomino Ln, Suite 703, Bedford, NH 03110 Phone: 603-858-1282 | |
Gina Chernosky, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8 Commerce Dr Ste 305, Bedford, NH 03110 Phone: 603-883-0005 Fax: 603-883-0007 | |
Elizabeth Frescoln, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 360 Route 101, Ste 10, Bedford, NH 03110 Phone: 603-472-2846 Fax: 603-472-2872 | |
Amy L Mercier, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 80 Palomino Ln Ste 101, Bedford, NH 03110 Phone: 603-819-3816 Fax: 603-606-1032 | |
Candice Porter, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 21 Middleton Dr, Bedford, NH 03110 Phone: 802-236-4847 | |
Kathleen M Corkery, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 360 Route 101, Ste 10, Bedford, NH 03110 Phone: 603-472-2846 Fax: 603-472-2872 | |
Mrs. Marissa Volpe, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10 Chestnut Dr Unit D, Bedford, NH 03110 Phone: 603-867-9158 Fax: 833-556-3593 |